NuGenerex Immuno-Oncology Inc – Material Contracts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Material Contracts Filter

from 10-12G/A 7 pages License and Research Agreement Between Antigen Express, Inc. (A Wholly-Owned Subsidiary of Generex Biotechnology Corporation) and Shenzhen Bioscien Pharmaceuticals Co. Ltd. November 29th, 2017 1

from 10-12G/A 3 pages Forbearance Agreement

from 8-K 8 pages Equity Purchase Agreement

from 10-12G/A 8 pages License and Research Agreement Between Antigen Express, Inc. (A Wholly-Owned Subsidiary of Generex Biotechnology Corporation) and Shenzhen Bioscien Pharmaceuticals Co. Ltd. November 29th, 2017 1

from 10-12G/A 34 pages Clinical Trial Agreement Phase II Study Between Nsabp Foundation, Inc. and Antigen Express, Inc

from 10-12G/A 110 pages Clinical Trial Collaboration and Supply Agreement by and Among Merck Sharp & Dohme B.V. and Antigen Express, Inc. Dated: June 28, 2017 -I